Global Pharmaceutical Cannabis Market Research Report 2022

SKU ID :QYR-21514424 | Published Date: 22-Aug-2022 | No. of pages: 89
1 Pharmaceutical Cannabis Market Overview 1.1 Product Overview and Scope of Pharmaceutical Cannabis 1.2 Pharmaceutical Cannabis Segment by Type 1.2.1 Global Pharmaceutical Cannabis Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 THC-dominant 1.2.3 CBD-dominant 1.2.4 Balanced THC & CBD 1.3 Pharmaceutical Cannabis Segment by Application 1.3.1 Global Pharmaceutical Cannabis Sales Comparison by Application: (2022-2028) 1.3.2 Cancer 1.3.3 Arthritis 1.3.4 Migraine 1.3.5 Epilepsy 1.3.6 Others 1.4 Global Pharmaceutical Cannabis Market Size Estimates and Forecasts 1.4.1 Global Pharmaceutical Cannabis Revenue 2017-2028 1.4.2 Global Pharmaceutical Cannabis Sales 2017-2028 1.4.3 Pharmaceutical Cannabis Market Size by Region: 2017 Versus 2021 Versus 2028 2 Pharmaceutical Cannabis Market Competition by Manufacturers 2.1 Global Pharmaceutical Cannabis Sales Market Share by Manufacturers (2017-2022) 2.2 Global Pharmaceutical Cannabis Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Pharmaceutical Cannabis Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Pharmaceutical Cannabis Manufacturing Sites, Area Served, Product Type 2.5 Pharmaceutical Cannabis Market Competitive Situation and Trends 2.5.1 Pharmaceutical Cannabis Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Pharmaceutical Cannabis Players Market Share by Revenue 2.5.3 Global Pharmaceutical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Pharmaceutical Cannabis Retrospective Market Scenario by Region 3.1 Global Pharmaceutical Cannabis Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Pharmaceutical Cannabis Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Pharmaceutical Cannabis Market Facts & Figures by Country 3.3.1 North America Pharmaceutical Cannabis Sales by Country 3.3.2 North America Pharmaceutical Cannabis Revenue by Country 3.3.3 United States 3.3.4 Canada 3.4 Europe Pharmaceutical Cannabis Market Facts & Figures by Country 3.4.1 Europe Pharmaceutical Cannabis Sales by Country 3.4.2 Europe Pharmaceutical Cannabis Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Pharmaceutical Cannabis Market Facts & Figures by Region 3.5.1 Asia Pacific Pharmaceutical Cannabis Sales by Region 3.5.2 Asia Pacific Pharmaceutical Cannabis Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 China Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.6 Latin America Pharmaceutical Cannabis Market Facts & Figures by Country 3.6.1 Latin America Pharmaceutical Cannabis Sales by Country 3.6.2 Latin America Pharmaceutical Cannabis Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Pharmaceutical Cannabis Market Facts & Figures by Country 3.7.1 Middle East and Africa Pharmaceutical Cannabis Sales by Country 3.7.2 Middle East and Africa Pharmaceutical Cannabis Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Pharmaceutical Cannabis Historic Market Analysis by Type 4.1 Global Pharmaceutical Cannabis Sales Market Share by Type (2017-2022) 4.2 Global Pharmaceutical Cannabis Revenue Market Share by Type (2017-2022) 4.3 Global Pharmaceutical Cannabis Price by Type (2017-2022) 5 Global Pharmaceutical Cannabis Historic Market Analysis by Application 5.1 Global Pharmaceutical Cannabis Sales Market Share by Application (2017-2022) 5.2 Global Pharmaceutical Cannabis Revenue Market Share by Application (2017-2022) 5.3 Global Pharmaceutical Cannabis Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Canopy Growth Corporation 6.1.1 Canopy Growth Corporation Corporation Information 6.1.2 Canopy Growth Corporation Description and Business Overview 6.1.3 Canopy Growth Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Canopy Growth Corporation Pharmaceutical Cannabis Product Portfolio 6.1.5 Canopy Growth Corporation Recent Developments/Updates 6.2 GW Pharmaceuticals, plc 6.2.1 GW Pharmaceuticals, plc Corporation Information 6.2.2 GW Pharmaceuticals, plc Description and Business Overview 6.2.3 GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.2.4 GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Portfolio 6.2.5 GW Pharmaceuticals, plc Recent Developments/Updates 6.3 Aurora Cannabis, Inc. 6.3.1 Aurora Cannabis, Inc. Corporation Information 6.3.2 Aurora Cannabis, Inc. Description and Business Overview 6.3.3 Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Portfolio 6.3.5 Aurora Cannabis, Inc. Recent Developments/Updates 6.4 Aphria, Inc. 6.4.1 Aphria, Inc. Corporation Information 6.4.2 Aphria, Inc. Description and Business Overview 6.4.3 Aphria, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Aphria, Inc. Pharmaceutical Cannabis Product Portfolio 6.4.5 Aphria, Inc. Recent Developments/Updates 6.5 MedReleaf Corporation 6.5.1 MedReleaf Corporation Corporation Information 6.5.2 MedReleaf Corporation Description and Business Overview 6.5.3 MedReleaf Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.5.4 MedReleaf Corporation Pharmaceutical Cannabis Product Portfolio 6.5.5 MedReleaf Corporation Recent Developments/Updates 6.6 Insys Therapeutics, Inc. 6.6.1 Insys Therapeutics, Inc. Corporation Information 6.6.2 Insys Therapeutics, Inc. Description and Business Overview 6.6.3 Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio 6.6.5 Insys Therapeutics, Inc. Recent Developments/Updates 6.7 CanniMed Therapeutics, Inc. 6.6.1 CanniMed Therapeutics, Inc. Corporation Information 6.6.2 CanniMed Therapeutics, Inc. Description and Business Overview 6.6.3 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.4.4 CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio 6.7.5 CanniMed Therapeutics, Inc. Recent Developments/Updates 6.8 Cara Therapeutics, Inc. 6.8.1 Cara Therapeutics, Inc. Corporation Information 6.8.2 Cara Therapeutics, Inc. Description and Business Overview 6.8.3 Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Portfolio 6.8.5 Cara Therapeutics, Inc. Recent Developments/Updates 6.9 United Cannabis Corporation 6.9.1 United Cannabis Corporation Corporation Information 6.9.2 United Cannabis Corporation Description and Business Overview 6.9.3 United Cannabis Corporation Pharmaceutical Cannabis Sales, Revenue and Gross Margin (2017-2022) 6.9.4 United Cannabis Corporation Pharmaceutical Cannabis Product Portfolio 6.9.5 United Cannabis Corporation Recent Developments/Updates 7 Pharmaceutical Cannabis Manufacturing Cost Analysis 7.1 Pharmaceutical Cannabis Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Pharmaceutical Cannabis 7.4 Pharmaceutical Cannabis Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Pharmaceutical Cannabis Distributors List 8.3 Pharmaceutical Cannabis Customers 9 Pharmaceutical Cannabis Market Dynamics 9.1 Pharmaceutical Cannabis Industry Trends 9.2 Pharmaceutical Cannabis Market Drivers 9.3 Pharmaceutical Cannabis Market Challenges 9.4 Pharmaceutical Cannabis Market Restraints 10 Global Market Forecast 10.1 Pharmaceutical Cannabis Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Pharmaceutical Cannabis by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Type (2023-2028) 10.2 Pharmaceutical Cannabis Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Pharmaceutical Cannabis by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Application (2023-2028) 10.3 Pharmaceutical Cannabis Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Pharmaceutical Cannabis by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Pharmaceutical Cannabis by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer
List of Tables Table 1. Global Pharmaceutical Cannabis Sales Growth Rate Comparison by Type (2022-2028) & (Kiloton) & (US$ Million) Table 2. Global Pharmaceutical Cannabis Sales Growth Rate Comparison by Application (2022-2028) & (Kiloton) & (US$ Million) Table 3. Global Pharmaceutical Cannabis Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Pharmaceutical Cannabis Market Competitive Situation by Manufacturers in 2021 Table 5. Global Pharmaceutical Cannabis Sales (Kiloton) of Key Manufacturers (2017-2022) Table 6. Global Pharmaceutical Cannabis Sales Market Share by Manufacturers (2017-2022) Table 7. Global Pharmaceutical Cannabis Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Pharmaceutical Cannabis Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Pharmaceutical Cannabis Average Price (US$/KG) of Key Manufacturers (2017-2022) Table 10. Manufacturers Pharmaceutical Cannabis Manufacturing Sites and Area Served Table 11. Manufacturers Pharmaceutical Cannabis Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Pharmaceutical Cannabis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceutical Cannabis as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Pharmaceutical Cannabis Sales by Region (2017-2022) & (Kiloton) Table 16. Global Pharmaceutical Cannabis Sales Market Share by Region (2017-2022) Table 17. Global Pharmaceutical Cannabis Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Pharmaceutical Cannabis Revenue Market Share by Region (2017-2022) Table 19. North America Pharmaceutical Cannabis Sales by Country (2017-2022) & (Kiloton) Table 20. North America Pharmaceutical Cannabis Sales Market Share by Country (2017-2022) Table 21. North America Pharmaceutical Cannabis Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022) Table 23. Europe Pharmaceutical Cannabis Sales by Country (2017-2022) & (Kiloton) Table 24. Europe Pharmaceutical Cannabis Sales Market Share by Country (2017-2022) Table 25. Europe Pharmaceutical Cannabis Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Pharmaceutical Cannabis Sales by Region (2017-2022) & (Kiloton) Table 28. Asia Pacific Pharmaceutical Cannabis Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Pharmaceutical Cannabis Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Pharmaceutical Cannabis Revenue Market Share by Region (2017-2022) Table 31. Latin America Pharmaceutical Cannabis Sales by Country (2017-2022) & (Kiloton) Table 32. Latin America Pharmaceutical Cannabis Sales Market Share by Country (2017-2022) Table 33. Latin America Pharmaceutical Cannabis Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Pharmaceutical Cannabis Sales by Country (2017-2022) & (Kiloton) Table 36. Middle East and Africa Pharmaceutical Cannabis Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Pharmaceutical Cannabis Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Pharmaceutical Cannabis Revenue Market Share by Country (2017-2022) Table 39. Global Pharmaceutical Cannabis Sales by Type (2017-2022) & (Kiloton) Table 40. Global Pharmaceutical Cannabis Sales Market Share by Type (2017-2022) Table 41. Global Pharmaceutical Cannabis Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Pharmaceutical Cannabis Revenue Share by Type (2017-2022) Table 43. Global Pharmaceutical Cannabis Price by Type (2017-2022) & (US$/KG) Table 44. Global Pharmaceutical Cannabis Sales (Kiloton) by Application (2017-2022) Table 45. Global Pharmaceutical Cannabis Sales Market Share by Application (2017-2022) Table 46. Global Pharmaceutical Cannabis Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Pharmaceutical Cannabis Revenue Share by Application (2017-2022) Table 48. Global Pharmaceutical Cannabis Price by Application (2017-2022) & (US$/KG) Table 49. Canopy Growth Corporation Corporation Information Table 50. Canopy Growth Corporation Description and Business Overview Table 51. Canopy Growth Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 52. Canopy Growth Corporation Pharmaceutical Cannabis Product Table 53. Canopy Growth Corporation Recent Developments/Updates Table 54. GW Pharmaceuticals, plc Corporation Information Table 55. GW Pharmaceuticals, plc Description and Business Overview Table 56. GW Pharmaceuticals, plc Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 57. GW Pharmaceuticals, plc Pharmaceutical Cannabis Product Table 58. GW Pharmaceuticals, plc Recent Developments/Updates Table 59. Aurora Cannabis, Inc. Corporation Information Table 60. Aurora Cannabis, Inc. Description and Business Overview Table 61. Aurora Cannabis, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 62. Aurora Cannabis, Inc. Pharmaceutical Cannabis Product Table 63. Aurora Cannabis, Inc. Recent Developments/Updates Table 64. Aphria, Inc. Corporation Information Table 65. Aphria, Inc. Description and Business Overview Table 66. Aphria, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 67. Aphria, Inc. Pharmaceutical Cannabis Product Table 68. Aphria, Inc. Recent Developments/Updates Table 69. MedReleaf Corporation Corporation Information Table 70. MedReleaf Corporation Description and Business Overview Table 71. MedReleaf Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 72. MedReleaf Corporation Pharmaceutical Cannabis Product Table 73. MedReleaf Corporation Recent Developments/Updates Table 74. Insys Therapeutics, Inc. Corporation Information Table 75. Insys Therapeutics, Inc. Description and Business Overview Table 76. Insys Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 77. Insys Therapeutics, Inc. Pharmaceutical Cannabis Product Table 78. Insys Therapeutics, Inc. Recent Developments/Updates Table 79. CanniMed Therapeutics, Inc. Corporation Information Table 80. CanniMed Therapeutics, Inc. Description and Business Overview Table 81. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 82. CanniMed Therapeutics, Inc. Pharmaceutical Cannabis Product Table 83. CanniMed Therapeutics, Inc. Recent Developments/Updates Table 84. Cara Therapeutics, Inc. Corporation Information Table 85. Cara Therapeutics, Inc. Description and Business Overview Table 86. Cara Therapeutics, Inc. Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 87. Cara Therapeutics, Inc. Pharmaceutical Cannabis Product Table 88. Cara Therapeutics, Inc. Recent Developments/Updates Table 89. United Cannabis Corporation Corporation Information Table 90. United Cannabis Corporation Description and Business Overview Table 91. United Cannabis Corporation Pharmaceutical Cannabis Sales (Kiloton), Revenue (US$ Million), Price (US$/KG) and Gross Margin (2017-2022) Table 92. United Cannabis Corporation Pharmaceutical Cannabis Product Table 93. United Cannabis Corporation Recent Developments/Updates Table 94. Production Base and Market Concentration Rate of Raw Material Table 95. Key Suppliers of Raw Materials Table 96. Pharmaceutical Cannabis Distributors List Table 97. Pharmaceutical Cannabis Customers List Table 98. Pharmaceutical Cannabis Market Trends Table 99. Pharmaceutical Cannabis Market Drivers Table 100. Pharmaceutical Cannabis Market Challenges Table 101. Pharmaceutical Cannabis Market Restraints Table 102. Global Pharmaceutical Cannabis Sales Forecast by Type (2023-2028) & (Kiloton) Table 103. Global Pharmaceutical Cannabis Sales Market Share Forecast by Type (2023-2028) Table 104. Global Pharmaceutical Cannabis Revenue Forecast by Type (2023-2028) & (US$ Million) Table 105. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Type (2023-2028) Table 106. Global Pharmaceutical Cannabis Sales Forecast by Application (2023-2028) & (Kiloton) Table 107. Global Pharmaceutical Cannabis Sales Market Share Forecast by Application (2023-2028) Table 108. Global Pharmaceutical Cannabis Revenue Forecast by Application (2023-2028) & (US$ Million) Table 109. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Application (2023-2028) Table 110. Global Pharmaceutical Cannabis Sales Forecast by Region (2023-2028) & (Kiloton) Table 111. Global Pharmaceutical Cannabis Sales Market Share Forecast by Region (2023-2028) Table 112. Global Pharmaceutical Cannabis Revenue Forecast by Region (2023-2028) & (US$ Million) Table 113. Global Pharmaceutical Cannabis Revenue Market Share Forecast by Region (2023-2028) Table 114. Research Programs/Design for This Report Table 115. Key Data Information from Secondary Sources Table 116. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Pharmaceutical Cannabis Figure 2. Global Pharmaceutical Cannabis Market Share by Type in 2021 & 2028 Figure 3. THC-dominant Product Picture Figure 4. CBD-dominant Product Picture Figure 5. Balanced THC & CBD Product Picture Figure 6. Global Pharmaceutical Cannabis Market Share by Application in 2021 & 2028 Figure 7. Cancer Figure 8. Arthritis Figure 9. Migraine Figure 10. Epilepsy Figure 11. Others Figure 12. Global Pharmaceutical Cannabis Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Pharmaceutical Cannabis Market Size (2017-2028) & (US$ Million) Figure 14. Global Pharmaceutical Cannabis Sales (2017-2028) & (Kiloton) Figure 15. Pharmaceutical Cannabis Sales Share by Manufacturers in 2021 Figure 16. Global Pharmaceutical Cannabis Revenue Share by Manufacturers in 2021 Figure 17. The Global 5 and 10 Largest Pharmaceutical Cannabis Players: Market Share by Revenue in 2021 Figure 18. Pharmaceutical Cannabis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 19. Global Pharmaceutical Cannabis Sales Market Share by Region (2017-2022) Figure 20. Global Pharmaceutical Cannabis Sales Market Share by Region in 2021 Figure 21. Global Pharmaceutical Cannabis Revenue Market Share by Region (2017-2022) Figure 22. Global Pharmaceutical Cannabis Revenue Market Share by Region in 2021 Figure 23. United States Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. Canada Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Germany Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. France Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. U.K. Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Italy Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Russia Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. China Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Japan Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. South Korea Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. India Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Australia Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. China Taiwan Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Indonesia Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Thailand Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Malaysia Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. UAE Pharmaceutical Cannabis Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Pharmaceutical Cannabis by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Pharmaceutical Cannabis Figure 47. Manufacturing Process Analysis of Pharmaceutical Cannabis Figure 48. Pharmaceutical Cannabis Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed
Canopy Growth Corporation GW Pharmaceuticals, plc Aurora Cannabis, Inc. Aphria, Inc. MedReleaf Corporation Insys Therapeutics, Inc. CanniMed Therapeutics, Inc. Cara Therapeutics, Inc. United Cannabis Corporation
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients